Setrobuvir

DB12051

small molecule investigational

Deskripsi

Setrobuvir has been used in trials studying the treatment of Hepatitis C, Chronic.

Struktur Molekul 2D

Berat 560.62
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

113 Data
Nicotine The risk or severity of adverse effects can be increased when Setrobuvir is combined with Nicotine.
Mecamylamine The risk or severity of adverse effects can be increased when Setrobuvir is combined with Mecamylamine.
Pentolinium The risk or severity of adverse effects can be increased when Setrobuvir is combined with Pentolinium.
Trimethaphan The risk or severity of adverse effects can be increased when Setrobuvir is combined with Trimethaphan.
Hexamethonium The risk or severity of adverse effects can be increased when Setrobuvir is combined with Hexamethonium.
Cyclopentamine The risk or severity of adverse effects can be increased when Setrobuvir is combined with Cyclopentamine.
Methotrexate The protein binding of Methotrexate can be increased when combined with Setrobuvir.
Ketoprofen The risk or severity of adverse effects can be increased when Ketoprofen is combined with Setrobuvir.
Dexketoprofen The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Setrobuvir.
Cyclosporine The risk or severity of renal failure can be increased when Setrobuvir is combined with Cyclosporine.
Insulin human The risk or severity of hypoglycemia can be increased when Setrobuvir is combined with Insulin human.
Insulin lispro The risk or severity of hypoglycemia can be increased when Setrobuvir is combined with Insulin lispro.
Insulin glargine The risk or severity of hypoglycemia can be increased when Setrobuvir is combined with Insulin glargine.
Insulin pork The risk or severity of hypoglycemia can be increased when Setrobuvir is combined with Insulin pork.
Troglitazone The therapeutic efficacy of Troglitazone can be increased when used in combination with Setrobuvir.
Glimepiride The therapeutic efficacy of Glimepiride can be increased when used in combination with Setrobuvir.
Sulfisoxazole The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Setrobuvir.
Disopyramide The therapeutic efficacy of Disopyramide can be increased when used in combination with Setrobuvir.
Acarbose The therapeutic efficacy of Acarbose can be increased when used in combination with Setrobuvir.
Metformin The therapeutic efficacy of Metformin can be increased when used in combination with Setrobuvir.
Sulfadiazine The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Setrobuvir.
Rosiglitazone The therapeutic efficacy of Rosiglitazone can be increased when used in combination with Setrobuvir.
Acetohexamide The therapeutic efficacy of Acetohexamide can be increased when used in combination with Setrobuvir.
Quinine The therapeutic efficacy of Quinine can be increased when used in combination with Setrobuvir.
Miglitol The therapeutic efficacy of Miglitol can be increased when used in combination with Setrobuvir.
Chlorpropamide The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Setrobuvir.
Nateglinide The therapeutic efficacy of Nateglinide can be increased when used in combination with Setrobuvir.
Pentamidine The therapeutic efficacy of Pentamidine can be increased when used in combination with Setrobuvir.
Mifepristone The therapeutic efficacy of Mifepristone can be increased when used in combination with Setrobuvir.
Tolazamide The therapeutic efficacy of Tolazamide can be increased when used in combination with Setrobuvir.
Repaglinide The therapeutic efficacy of Repaglinide can be increased when used in combination with Setrobuvir.
Phenformin The therapeutic efficacy of Phenformin can be increased when used in combination with Setrobuvir.
Sulfamethoxazole The therapeutic efficacy of Sulfamethoxazole can be increased when used in combination with Setrobuvir.
Glyburide The therapeutic efficacy of Glyburide can be increased when used in combination with Setrobuvir.
Glipizide The therapeutic efficacy of Glipizide can be increased when used in combination with Setrobuvir.
Gliclazide The therapeutic efficacy of Gliclazide can be increased when used in combination with Setrobuvir.
Tolbutamide The therapeutic efficacy of Tolbutamide can be increased when used in combination with Setrobuvir.
Pioglitazone The therapeutic efficacy of Pioglitazone can be increased when used in combination with Setrobuvir.
Bromocriptine The therapeutic efficacy of Bromocriptine can be increased when used in combination with Setrobuvir.
Gliquidone The therapeutic efficacy of Gliquidone can be increased when used in combination with Setrobuvir.
Mitiglinide The therapeutic efficacy of Mitiglinide can be increased when used in combination with Setrobuvir.
Sitagliptin The therapeutic efficacy of Sitagliptin can be increased when used in combination with Setrobuvir.
Sunitinib The therapeutic efficacy of Sunitinib can be increased when used in combination with Setrobuvir.
Exenatide The therapeutic efficacy of Exenatide can be increased when used in combination with Setrobuvir.
Mecasermin The therapeutic efficacy of Mecasermin can be increased when used in combination with Setrobuvir.
Pramlintide The therapeutic efficacy of Pramlintide can be increased when used in combination with Setrobuvir.
Glisoxepide The therapeutic efficacy of Glisoxepide can be increased when used in combination with Setrobuvir.
Insulin aspart The risk or severity of hypoglycemia can be increased when Setrobuvir is combined with Insulin aspart.
Insulin detemir The risk or severity of hypoglycemia can be increased when Setrobuvir is combined with Insulin detemir.
Insulin glulisine The risk or severity of hypoglycemia can be increased when Setrobuvir is combined with Insulin glulisine.
Glymidine The therapeutic efficacy of Glymidine can be increased when used in combination with Setrobuvir.
AICA ribonucleotide The therapeutic efficacy of AICA ribonucleotide can be increased when used in combination with Setrobuvir.
Buformin The therapeutic efficacy of Buformin can be increased when used in combination with Setrobuvir.
Vildagliptin The therapeutic efficacy of Vildagliptin can be increased when used in combination with Setrobuvir.
Voglibose The therapeutic efficacy of Voglibose can be increased when used in combination with Setrobuvir.
NN344 The risk or severity of hypoglycemia can be increased when Setrobuvir is combined with NN344.
AMG-222 The therapeutic efficacy of AMG-222 can be increased when used in combination with Setrobuvir.
Bisegliptin The therapeutic efficacy of Bisegliptin can be increased when used in combination with Setrobuvir.
Alogliptin The therapeutic efficacy of Alogliptin can be increased when used in combination with Setrobuvir.
Dapagliflozin The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Setrobuvir.
Saxagliptin The therapeutic efficacy of Saxagliptin can be increased when used in combination with Setrobuvir.
Liraglutide The therapeutic efficacy of Liraglutide can be increased when used in combination with Setrobuvir.
Gosogliptin The therapeutic efficacy of Gosogliptin can be increased when used in combination with Setrobuvir.
Linagliptin The therapeutic efficacy of Linagliptin can be increased when used in combination with Setrobuvir.
Canagliflozin The therapeutic efficacy of Canagliflozin can be increased when used in combination with Setrobuvir.
Glibornuride The therapeutic efficacy of Glibornuride can be increased when used in combination with Setrobuvir.
Benfluorex The therapeutic efficacy of Benfluorex can be increased when used in combination with Setrobuvir.
Empagliflozin The therapeutic efficacy of Empagliflozin can be increased when used in combination with Setrobuvir.
Albiglutide The therapeutic efficacy of Albiglutide can be increased when used in combination with Setrobuvir.
Dulaglutide The therapeutic efficacy of Dulaglutide can be increased when used in combination with Setrobuvir.
Lobeglitazone The therapeutic efficacy of Lobeglitazone can be increased when used in combination with Setrobuvir.
Netoglitazone The therapeutic efficacy of Netoglitazone can be increased when used in combination with Setrobuvir.
Rivoglitazone The therapeutic efficacy of Rivoglitazone can be increased when used in combination with Setrobuvir.
Ciglitazone The therapeutic efficacy of Ciglitazone can be increased when used in combination with Setrobuvir.
Lixisenatide The therapeutic efficacy of Lixisenatide can be increased when used in combination with Setrobuvir.
Insulin beef The risk or severity of hypoglycemia can be increased when Setrobuvir is combined with Insulin beef.
Insulin degludec The risk or severity of hypoglycemia can be increased when Setrobuvir is combined with Insulin degludec.
Insulin peglispro The risk or severity of hypoglycemia can be increased when Setrobuvir is combined with Insulin peglispro.
Insulin tregopil The risk or severity of hypoglycemia can be increased when Setrobuvir is combined with Insulin tregopil.
Ipragliflozin The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Setrobuvir.
Dutogliptin The therapeutic efficacy of Dutogliptin can be increased when used in combination with Setrobuvir.
Allicin The therapeutic efficacy of Allicin can be increased when used in combination with Setrobuvir.
Tofogliflozin The therapeutic efficacy of Tofogliflozin can be increased when used in combination with Setrobuvir.
Ertugliflozin The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Setrobuvir.
2,4-thiazolidinedione The therapeutic efficacy of 2,4-thiazolidinedione can be increased when used in combination with Setrobuvir.
Teneligliptin The therapeutic efficacy of Teneligliptin can be increased when used in combination with Setrobuvir.
Omarigliptin The therapeutic efficacy of Omarigliptin can be increased when used in combination with Setrobuvir.
Carmegliptin The therapeutic efficacy of Carmegliptin can be increased when used in combination with Setrobuvir.
Gemigliptin The therapeutic efficacy of Gemigliptin can be increased when used in combination with Setrobuvir.
Anagliptin The therapeutic efficacy of Anagliptin can be increased when used in combination with Setrobuvir.
Evogliptin The therapeutic efficacy of Evogliptin can be increased when used in combination with Setrobuvir.
Sotagliflozin The therapeutic efficacy of Sotagliflozin can be increased when used in combination with Setrobuvir.
Balaglitazone The therapeutic efficacy of Balaglitazone can be increased when used in combination with Setrobuvir.
Remogliflozin etabonate The therapeutic efficacy of Remogliflozin etabonate can be increased when used in combination with Setrobuvir.
Carbutamide The therapeutic efficacy of Carbutamide can be increased when used in combination with Setrobuvir.
Guar gum The therapeutic efficacy of Guar gum can be increased when used in combination with Setrobuvir.
Metahexamide The therapeutic efficacy of Metahexamide can be increased when used in combination with Setrobuvir.
Semaglutide The therapeutic efficacy of Semaglutide can be increased when used in combination with Setrobuvir.
Taspoglutide The therapeutic efficacy of Taspoglutide can be increased when used in combination with Setrobuvir.
Englitazone The therapeutic efficacy of Englitazone can be increased when used in combination with Setrobuvir.

Target Protein

Genome polyprotein

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul